Literature DB >> 11418467

Highly abundant genes in the transcriptosome of human and baboon CD34 antigen-positive bone marrow cells.

I Gomes1, T T Sharma, N Mahmud, J D Kapp, S Edassery, N Fulton, J Liang, R Hoffman, C A Westbrook.   

Abstract

Nonhuman primates are useful large animal model systems for the in vivo study of hematopoietic stem cell biology. To better understand the degree of similarity of the hematopoietic systems between humans and baboons, and to explore the relevance of such studies in nonhuman primates to humans, this study was designed to compare the global gene expression profile of bone marrow CD34(+) cells isolated from these 2 species. Human complementary DNA (cDNA) filter arrays containing 25 920 human cDNAs were surveyed for this purpose. The expression pattern and relative gene abundance of the 2 RNA sources were similar, with a correlation coefficient of 0.87. A total of 15 970 of these cDNAs were expressed in human CD34(+) cells, of which the majority (96%) varied less than 3-fold in their relative level of expression between human and baboon. Reverse transcriptase-polymerase chain reaction analysis of selected genes confirmed that expression was comparable between the 2 species. No species-restricted transcripts have been identified, further reinforcing the high degree of similarity between the 2 populations. A subset of 1554 cDNAs, which are expressed at levels 100-fold and greater than background, is described, which includes 959 expressed sequence tags and uncharacterized cDNAs, and 595 named genes, including many that are clearly involved in hematopoiesis. The cDNAs reported here represent a selection of some of the most highly abundant genes in hematopoietic cells and provide a starting point to develop a profile of the transcriptosome of CD34(+) cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418467     DOI: 10.1182/blood.v98.1.93

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Skeletogenic Capacity of Human Perivascular Stem Cells Obtained Via Magnetic-Activated Cell Sorting.

Authors:  Carolyn A Meyers; Jiajia Xu; Leititia Zhang; Leslie Chang; Yiyun Wang; Greg Asatrian; Catherine Ding; Noah Yan; Erin Zou; Kristen Broderick; Min Lee; Bruno Peault; Aaron W James
Journal:  Tissue Eng Part A       Date:  2019-08-16       Impact factor: 3.845

2.  Immune and inflammatory pathways are involved in inherent bone marrow ossification.

Authors:  Umut Atakan Gurkan; Ryan Golden; Vipuil Kishore; Catherine P Riley; Jiri Adamec; Ozan Akkus
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

3.  Innate immune responses to TLR2 and TLR4 agonists differ between baboons, chimpanzees and humans.

Authors:  J F Brinkworth; E A Pechenkina; J Silver; S M Goyert
Journal:  J Med Primatol       Date:  2012-09-17       Impact factor: 0.667

4.  Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation.

Authors:  Richa Bedi; Jian Du; Arun K Sharma; Ignatius Gomes; Steven J Ackerman
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

5.  Temporal dynamics of gene expression in the lung in a baboon model of E. coli sepsis.

Authors:  Hua Zhu; Yuhong Tang; Lacramioara Ivanciu; Michael Centola; Cristina Lupu; Fletcher B Taylor; Florea Lupu
Journal:  BMC Genomics       Date:  2007-02-26       Impact factor: 3.969

6.  Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies.

Authors:  Hans-Peter Kiem; Paritha I Arumugam; Christopher R Burtner; Catherine F Fox; Brian C Beard; Phillip Dexheimer; Jennifer E Adair; Punam Malik
Journal:  Mol Ther Methods Clin Dev       Date:  2014-12-17       Impact factor: 6.698

7.  Lung dendritic cell developmental programming, environmental stimuli, and asthma in early periods of life.

Authors:  Shanjana Awasthi; Bhupinder Singh; Robert C Welliver; Rodney R Dietert
Journal:  J Allergy (Cairo)       Date:  2012-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.